Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Thornton

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Journal of the American Pharmacists Association : Japha|April 17, 2025
Effects of the Prescription Drug Monitoring Program Mandate on Queries of Controlled Substance Prescriptions: Findings from TexasOlajumoke A Olateju, Mina Shrestha, Alia Altaie, et al.
American Journal of Clinical Oncology|June 28, 2024
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint InhibitorsOlajumoke A Olateju, Osaro Mgbere, J Douglas Thornton, et al.
Journal of Palliative Care|November 24, 2025
Impact of Hydrocodone Rescheduling on Pharmaceutical Pain Management in End-of-Life Lung Cancer PatientsChan Shen, Mohammad Ikram, Shouhao Zhou, et al.
Pharmacy Practice|March 25, 2020
Differences between pharmacists' perception of counseling and practice in the era of prescription drug misuseJ Douglas Thornton, Precious Anyanwu, Vaishnavi Tata, et al.
BMC Cancer|July 13, 2023
Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitorsOlajumoke A Olateju, Zhen Zeng, J Douglas Thornton, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Effects of Hydrocodone Rescheduling on Pain Management Practices Among Older Breast Cancer PatientsChan Shen, Mohammad Ikram, Shouhao Zhou, et al.
Cancers|July 12, 2025
Hydrocodone Rescheduling and Opioid Prescribing Disparities in Breast Cancer PatientsChan Shen, Mohammad Ikram, Shouhao Zhou, et al.
Drug and Alcohol Dependence Reports|March 11, 2024
Leveraging prescription monitoring program data to evaluate the implementation of buprenorphine telehealth flexibilities: An interrupted time series analysis in TexasWhanhui Chi, Chijioke Okeke, Douglas Thornton, et al.
Research in Social & Administrative Pharmacy : RSAP|December 15, 2020
Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medicationsCallie G Downs, Tyler J Varisco, Shweta S Bapat, et al.
Journal of the American Pharmacists Association : Japha|February 13, 2021
Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacistsVaishnavi Tata, Tyler J Varisco, Nathan Du, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Journal of the American Pharmacists Association : Japha|April 17, 2025
Effects of the Prescription Drug Monitoring Program Mandate on Queries of Controlled Substance Prescriptions: Findings from TexasOlajumoke A Olateju, Mina Shrestha, Alia Altaie, et al.
American Journal of Clinical Oncology|June 28, 2024
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint InhibitorsOlajumoke A Olateju, Osaro Mgbere, J Douglas Thornton, et al.
Journal of Palliative Care|November 24, 2025
Impact of Hydrocodone Rescheduling on Pharmaceutical Pain Management in End-of-Life Lung Cancer PatientsChan Shen, Mohammad Ikram, Shouhao Zhou, et al.
Pharmacy Practice|March 25, 2020
Differences between pharmacists' perception of counseling and practice in the era of prescription drug misuseJ Douglas Thornton, Precious Anyanwu, Vaishnavi Tata, et al.
BMC Cancer|July 13, 2023
Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitorsOlajumoke A Olateju, Zhen Zeng, J Douglas Thornton, et al.
Current Oncology (Toronto, Ont.)|November 26, 2025
Effects of Hydrocodone Rescheduling on Pain Management Practices Among Older Breast Cancer PatientsChan Shen, Mohammad Ikram, Shouhao Zhou, et al.
Cancers|July 12, 2025
Hydrocodone Rescheduling and Opioid Prescribing Disparities in Breast Cancer PatientsChan Shen, Mohammad Ikram, Shouhao Zhou, et al.
Drug and Alcohol Dependence Reports|March 11, 2024
Leveraging prescription monitoring program data to evaluate the implementation of buprenorphine telehealth flexibilities: An interrupted time series analysis in TexasWhanhui Chi, Chijioke Okeke, Douglas Thornton, et al.
Research in Social & Administrative Pharmacy : RSAP|December 15, 2020
Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medicationsCallie G Downs, Tyler J Varisco, Shweta S Bapat, et al.
Journal of the American Pharmacists Association : Japha|February 13, 2021
Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacistsVaishnavi Tata, Tyler J Varisco, Nathan Du, et al.
Pageof 9